Allergy drug dupilumab tested as potential hair loss treatment
Disease control
Recruiting now
This study tests whether dupilumab, a drug used for allergies and eczema, can help regrow hair in people with moderate-to-severe alopecia areata who also have allergies or high IgE levels. Participants receive weekly injections of dupilumab or a placebo for 48 weeks, followed by …
Phase: PHASE2 • Sponsor: Emma Guttman • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC